Bacterin International Holdings, Inc.
| NYSE MKT: BONE
Bacterin International Holdings, Inc. develops and manufactures biologics products to domestic and international markets. The company designs, manufactures and markets bone graft materials, biological scaffolds and related medical devices. Its products are used in applications, including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and subcondral bone defect repair in knee and other joint surgeries. The company operates through two divisions: Biologics and Medical Devices. The Biologics division manufactures and sells human tissue-based products, primarily allograft, in the medical marketplace. The Medical Device division develops medical devices intended for use in several diverse clinical areas, including orthopedic, plastic, and cardiovascular surgery and it also develops custom surgical instrument kits for use with allografts processed by Biologics division. The company also develops coatings for medical devices, particularly antimicrobial-based coatings. Bacterin International Holdings was founded by Guy S. Cook in 1998 and is headquartered in Belgrade, MT.